{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:35:35Z","timestamp":1789720535877,"version":"4.0.1"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Glaucoma is a group of optic neuropathies characterized by the progressive degeneration of retinal ganglion cells (RGCs) as well as their axons leading to irreversible loss of sight. Medical management of the intraocular pressure (IOP) still represents the gold standard in glaucoma therapy, which only manages a single risk factor and does not directly address the neurodegenerative component of this eye disease. Recently, our group showed that antibody-derived immunopeptides (encoding complementarity-determining regions, CDRs) provide attractive glaucoma medication candidates and directly interfere its pathogenic mechanisms by different modes of action. In accordance with these findings, the present study showed the synthetic complementary-determining region 2 (CDR2) peptide (INSDGSSTSYADSVK) significantly increased RGC viability <jats:italic>in vitro<\/jats:italic> in a concentration-dependent manner (<jats:italic>p<\/jats:italic> &amp;lt; 0.05 using a CDR2 concentration of 50 \u03bcg\/mL). Employing state-of the-art immunoprecipitation experiments, we confirmed that synthetic CDR2 exhibited a high affinity toward the retinal target protein histone H3.1 (HIST1H3A) (<jats:italic>p<\/jats:italic> &amp;lt; 0.001 and log2-fold change &amp;gt; 3). Furthermore, molecular dynamics (MD) simulations along with virtual docking analyses predicted potential CDR2-specific binding regions of HIST1H3A, which might represent essential post-translational modification (PTM) sites for epigenetic regulations. Quantitative mass spectrometry (MS) analysis of retinas demonstrated 39 proteins significantly affected by CDR2 treatment (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). An up-regulation of proteins involved in the energy production (e.g., ATP5F1B and MT-CO2) as well as the regulatory ubiquitin proteasome system (e.g., PSMC5) was induced by the synthetic CDR2 peptide. On the other hand, CDR2 reduced metabolic key enzymes (e.g., DDAH1 and MAOB) as well as ER stress-related proteins (e.g., SEC22B and VCP) and these data were partially confirmed by microarray technology. Our outcome measurements indicate that specific protein-peptide interactions influence the regulatory epigenetic function of HIST1H3A promoting the neuroprotective mechanism on RGCs <jats:italic>in vitro<\/jats:italic>. In addition to IOP management, such synthetic peptides as CDR2 might serve as a synergistic immunotherapy for glaucoma in the future.<\/jats:p>","DOI":"10.3389\/fmed.2022.993351","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T04:47:55Z","timestamp":1665722875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1"],"prefix":"10.3389","volume":"9","author":[{"given":"Kristian Nzogang","family":"Fomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Schmelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Beutgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natarajan","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokul","family":"Govind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Grus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review.","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","article-title":"Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas.","volume":"50","author":"Nadal-Nicol\u00e1s","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.705405","article-title":"Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage.","volume":"12","author":"Conti","year":"2021","journal-title":"Front Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.824885","article-title":"Caffeine protects against retinal inflammation.","volume":"12","author":"Conti","year":"2021","journal-title":"Front Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084107","article-title":"A monoclonal anti-HMGB1 antibody attenuates neurodegeneration in an experimental animal model of glaucoma.","volume":"23","author":"Tonner","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06702-1","article-title":"Decelerated neurodegeneration after intravitreal injection of \u03b1-synuclein antibodies in a glaucoma animal model.","volume":"7","author":"Teister","year":"2017","journal-title":"Sci Rep."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.697586","article-title":"Therapeutic peptides targeting PPI in clinical development: overview, mechanism of action and perspectives.","volume":"8","author":"Cabri","year":"2021","journal-title":"Front Mol Biosci."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002371","article-title":"Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.","volume":"3","author":"Polonelli","year":"2008","journal-title":"PLoS One."},{"key":"B9","doi-asserted-by":"publisher","first-page":"14912","DOI":"10.1074\/jbc.M111.322362","article-title":"\u03b2-Actin-binding complementarity-determining region 2 of variable heavy chain from monoclonal antibody C7 induces apoptosis in several human tumor cells and is protective against metastatic melanoma.","volume":"287","author":"Arruda","year":"2012","journal-title":"J Biol Chem."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/srep14310","article-title":"A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.","volume":"5","author":"Figueiredo","year":"2015","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01132","article-title":"Blockade of MIF-CD74 signalling on macrophages and dendritic cells restores the antitumour immune response against metastatic melanoma.","volume":"9","author":"Figueiredo","year":"2018","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/2211-5463.12080","article-title":"AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model.","volume":"6","author":"Raba\u00e7a","year":"2016","journal-title":"FEBS Open Bio."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1093\/hmg\/ddx332","article-title":"Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG).","volume":"26","author":"Schmelter","year":"2017","journal-title":"Hum Mol Genet."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081222","article-title":"Synthetic polyclonal-derived CDR peptides as an innovative strategy in glaucoma therapy.","volume":"8","author":"Schmelter","year":"2019","journal-title":"J Clin Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9081013","article-title":"Regulation of the HTRA2 protease activity by an inhibitory antibody-derived peptide ligand and the influence on HTRA2-specific protein interaction networks in retinal tissues.","volume":"9","author":"Schmelter","year":"2021","journal-title":"Biomedicines."},{"key":"B16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jnc.13765","article-title":"Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture.","volume":"139","author":"Bell","year":"2016","journal-title":"J Neurochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis.","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods."},{"key":"B18","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data.","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/bfgp\/elq004","article-title":"Advances in porcine genomics and proteomics\u2013a toolbox for developing the pig as a model organism for molecular biomedical research.","volume":"9","author":"Bendixen","year":"2010","journal-title":"Brief Funct Genomics."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30032-5","article-title":"Proteomics unravels the regulatory mechanisms in human tears following acute renouncement of contact lens use: a comparison between hard and soft lenses.","volume":"8","author":"Manicam","year":"2018","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.06.001","article-title":"Autophagy in glaucoma: crosstalk with apoptosis and its implications.","volume":"117","author":"Wang","year":"2015","journal-title":"Brain Res Bull."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application.","volume":"11","author":"Xie","year":"2020","journal-title":"Front Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications.","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.cell.2013.01.032","article-title":"Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer.","volume":"152","author":"Tropberger","year":"2013","journal-title":"Cell."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4161\/cc.8.11.8620","article-title":"Histone H3-K56 acetylation is important for genomic stability in mammals.","volume":"8","author":"Yuan","year":"2009","journal-title":"Cell Cycle."},{"key":"B26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/15592294.2021.1922198","article-title":"Potential functions of histone H3.3 lysine 56 acetylation in mammals.","volume":"17","author":"Fang","year":"2022","journal-title":"Epigenetics."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01632","article-title":"Acetylation of histone H3 at lysine 64 regulates nucleosome dynamics and facilitates transcription.","volume":"3","author":"Di Cerbo","year":"2014","journal-title":"Elife."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0700-7","article-title":"Peptides as epigenetic modulators: therapeutic implications.","volume":"11","author":"Janssens","year":"2019","journal-title":"Clin Epigenetics."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.neurobiolaging.2012.12.028","article-title":"Disruption of neocortical histone H3 homeostasis by soluble A\u03b2: implications for Alzheimer\u2019s disease.","volume":"34","author":"Lithner","year":"2013","journal-title":"Neurobiol Aging."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/srep36328","article-title":"\u03b1-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses.","volume":"6","author":"Sugeno","year":"2016","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.7150\/ijms.43140","article-title":"The role of histone acetyltransferases and histone deacetylases in photoreceptor differentiation and degeneration.","volume":"17","author":"Zhao","year":"2020","journal-title":"Int J Med Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.exer.2005.03.014","article-title":"The pig eye as a novel model of glaucoma.","volume":"81","author":"Ruiz-Ederra","year":"2005","journal-title":"Exp Eye Res."},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-46430-4","author":"Christen","year":"2016","journal-title":"Biochemie und Molekularbiologie."},{"key":"B34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0959-4388(00)00237-3","article-title":"Energy as a constraint on the coding and processing of sensory information.","volume":"11","author":"Laughlin","year":"2001","journal-title":"Curr Opin Neurobiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-5793(95)01431-4","article-title":"Control of apoptosis by the cellular ATP level.","volume":"378","author":"Richter","year":"1996","journal-title":"FEBS Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice.","volume":"355","author":"Williams","year":"2017","journal-title":"Science."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.freeradbiomed.2012.07.021","article-title":"Cytochrome c oxidase dysfunction in oxidative stress.","volume":"53","author":"Srinivasan","year":"2012","journal-title":"Free Radic Biol Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.freeradbiomed.2005.03.025","article-title":"Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma.","volume":"39","author":"Ko","year":"2005","journal-title":"Free Radic Biol Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0306-4522(01)00493-6","article-title":"Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells.","volume":"109","author":"Geiger","year":"2002","journal-title":"Neuroscience."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.768996","article-title":"Metabolic fuel for epigenetic: nuclear production meets local consumption.","volume":"12","author":"Boon","year":"2021","journal-title":"Front Genet."},{"key":"B41","first-page":"255","article-title":"The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.","volume":"3","author":"Wang","year":"2006","journal-title":"Cell Mol Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s12035-012-8391-5","article-title":"The ubiquitin-proteasome system in retinal health and disease.","volume":"47","author":"Campello","year":"2013","journal-title":"Mol Neurobiol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep15859","article-title":"Annexin A2 binds to endosomes and negatively regulates TLR4-triggered inflammatory responses via the TRAM-TRIF pathway.","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02219-7","article-title":"Recombinant annexin A2 inhibits peripheral leukocyte activation and brain infiltration after traumatic brain injury.","volume":"18","author":"Liu","year":"2021","journal-title":"J Neuroinflammation."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0594-1","article-title":"Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.","volume":"36","author":"Feng","year":"2017","journal-title":"J Exp Clin Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3892\/etm.2019.7909","article-title":"Annexin A2 upregulation protects human retinal endothelial cells from oxygen-glucose deprivation injury by activating autophagy.","volume":"18","author":"Jiang","year":"2019","journal-title":"Exp Ther Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/ATVBAHA.110.222638","article-title":"Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.","volume":"31","author":"Hu","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0560-2","article-title":"Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.","volume":"16","author":"Greco","year":"2015","journal-title":"J Headache Pain."},{"key":"B49","doi-asserted-by":"publisher","first-page":"33995","DOI":"10.1074\/jbc.M108983200","article-title":"Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury.","volume":"277","author":"Cardounel","year":"2002","journal-title":"J Biol Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1476-5381.1993.tb13985.x","article-title":"Regional and cardiac haemodynamic effects of NG, NG, dimethyl-L-arginine and their reversibility by vasodilators in conscious rats.","volume":"110","author":"Gardiner","year":"1993","journal-title":"Br J Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.1074\/jbc.M410241200","article-title":"Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin.","volume":"280","author":"Cardounel","year":"2005","journal-title":"J Biol Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1161\/01.ATV.0000141843.77133.fc","article-title":"Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence.","volume":"24","author":"Scalera","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"493.e1","DOI":"10.1016\/j.ahj.2006.06.005","article-title":"Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter coronary artery risk determination investigating the influence of ADMA concentration (CARDIAC) study.","volume":"152","author":"Schulze","year":"2006","journal-title":"Am Heart J."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9093026","article-title":"ADMA: a key player in the relationship between vascular dysfunction and inflammation in atherosclerosis.","volume":"9","author":"Dowsett","year":"2020","journal-title":"J Clin Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2005.06.033","article-title":"Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.","volume":"185","author":"Wanby","year":"2006","journal-title":"Atherosclerosis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1167\/iovs.11-8420","article-title":"Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.","volume":"53","author":"Javadiyan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000312527","article-title":"Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis.","volume":"18","author":"Isobe","year":"2010","journal-title":"Neurosignals."},{"key":"B58","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2012.03.015","article-title":"Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.","volume":"318","author":"Ljubisavljevic","year":"2012","journal-title":"J Neurol Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/s0304-3940(01)02214-5","article-title":"Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer\u2019s disease.","volume":"312","author":"Abe","year":"2001","journal-title":"Neurosci Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.nbd.2010.07.004","article-title":"Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression.","volume":"40","author":"Siddiqui","year":"2010","journal-title":"Neurobiol Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/abbi.1996.0510","article-title":"The metabolism of tyramine by monoamine oxidase A\/B causes oxidative damage to mitochondrial DNA.","volume":"335","author":"Hauptmann","year":"1996","journal-title":"Arch Biochem Biophys."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","article-title":"Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type.","volume":"27","author":"Adolfsson","year":"1980","journal-title":"Life Sci."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001616","article-title":"MAO-B elevation in mouse brain astrocytes results in Parkinson\u2019s pathology.","volume":"3","author":"Mallajosyula","year":"2008","journal-title":"PLoS One."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2174\/156802612805219950","article-title":"Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.","volume":"12","author":"Naoi","year":"2012","journal-title":"Curr Top Med Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"10657","DOI":"10.1074\/jbc.M114.626911","article-title":"Examination of Sec22 homodimer formation and role in SNARE-dependent membrane fusion.","volume":"290","author":"Flanagan","year":"2015","journal-title":"J Biol Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.1074\/jbc.M115.640920","article-title":"Sec22 regulates endoplasmic reticulum morphology but not autophagy and is required for eye development in Drosophila.","volume":"290","author":"Zhao","year":"2015","journal-title":"J Biol Chem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"45676","DOI":"10.1074\/jbc.M409034200","article-title":"AAA ATPase p97\/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.","volume":"279","author":"Zhong","year":"2004","journal-title":"J Biol Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1242\/jcs.00841","article-title":"RNA interference of valosin-containing protein (VCP\/p97) reveals multiple cellular roles linked to ubiquitin\/proteasome-dependent proteolysis.","volume":"117","author":"W\u00f3jcik","year":"2004","journal-title":"J Cell Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1091\/mbc.e06-05-0432","article-title":"Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.","volume":"17","author":"W\u00f3jcik","year":"2006","journal-title":"Mol Biol Cell."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.993351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T04:48:00Z","timestamp":1665722880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.993351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":70,"alternative-id":["10.3389\/fmed.2022.993351"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.993351","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"article-number":"993351"}}